This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Why Is Steris (STE) Up 5.8% Since Last Earnings Report?
by Zacks Equity Research
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Edwards Lifesciences (EW) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thermo Fisher Scientific (TMO) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $591.50 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close.
Idexx (IDXX) Down 1.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Thermo Fisher (TMO) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Investors Heavily Search Thermo Fisher Scientific Inc. (TMO): Here is What You Need to Know
by Zacks Equity Research
Thermo Fisher (TMO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $570.18, denoting a -0.32% change from the preceding trading day.
Thermo Fisher (TMO) Introduces Dionex Inuvion IC system
by Zacks Equity Research
Thermo Fisher's (TMO) Dionex Inuvion system helps labs operate more effectively by providing simple, adjustable workflows and a small footprint.
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac
by Zacks Equity Research
Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac are included in this Analyst Blog.
Earnings Season Scorecard and Analyst Reports for Thermo Fisher, Philip Morris & General Dynamics
by Sheraz Mian
Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD).
Take the Zacks Approach to Beat the Market: NVIDIA, Carrols, CyberArk in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Thermo Fisher (TMO) Q4 Earnings Top Estimates, Gross Margin Down
by Zacks Equity Research
Strength in PPI business contributed to Thermo Fisher's (TMO) fourth-quarter revenue growth.
Thermo Fisher (TMO) End Market Growth Strong Despite Macro Woes
by Zacks Equity Research
Thermo Fisher's (TMO) electron microscopy, chromatography and mass spectrometry businesses are delivering strong growth in the academic and government end market.
Thermo Fisher (TMO) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Thermo Fisher (TMO) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Thermo Fisher Scientific (TMO) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 0.53% and 1.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Q4 Earnings Due on Jan 31: BSX, TMO & ALGN
by Urmimala Biswas
Medical Products companies' fourth-quarter results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO and ALGN fare this time.
Beat the Market the Zacks Way: Rolls-Royce, Costco, e.l.f. Beauty in Focus
by Santanu Roy
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Thermo Fisher (TMO) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Thermo Fisher (TMO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
Thermo Fisher Scientific (TMO) Laps the Stock Market: Here's Why
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $553.39 in the latest trading session, marking a +0.3% move from the prior day.
Thermo Fisher Scientific (TMO) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $544.42, marking a +0.96% move from the previous day.
Here's Why Investors Should Retain Thermo Fisher (TMO) Stock
by Zacks Equity Research
Investors continue to be optimistic about Thermo Fisher (TMO) due to its series of new product launches and promising growth strategy.
What's in Store for Thermo Fisher (TMO) in Q4 Earnings?
by Zacks Equity Research
Thermo Fisher (TMO) will likely gain from strong Analytical Instrument business performance and the latest strategic pacts.
Thermo Fisher Scientific (TMO) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
The latest trading day saw Thermo Fisher Scientific (TMO) settling at $544.32, representing a -0.31% change from its previous close.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $546 at the closing of the latest trading day, reflecting a +0.38% change compared to its last close.
Thermo Fisher Scientific (TMO) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
Thermo Fisher Scientific (TMO) reachead $531.23 at the closing of the latest trading day, reflecting a -1.14% change compared to its last close.